Alerta Epidemiológica: Uso indebido de medicamentos agonistas del receptor GLP-1 y sus consideraciones para la Región de las Américas

Stakeholder Perceptions on Innovative Private Pharmacy Distribution Channels and Implications for Medicine Quality in Zambia: A Qualitative Study

Systematic Pharmacovigilance and Genetic Validation of Medications Associated With Organizing Pneumonia: Integrating FAERS Data With Multiomics Analysis

Artificial intelligence revolution in toxicology: Clinical precision, global equity, and the 2030 roadmap

INTERGENERATIONAL TRANSMISSION OF SMUGGLING AS A PROFESSION

New Deprescribing Guidance Marks an ‘Important Moment’ in Psychiatry

Alteraciones del metabolismo lipídico inducidas por fármacos: un análisis exploratorio de farmacovigilancia del mundo real basado en el sistema de notificación de eventos adversos de la FDA de EE. UU. (FAERS)

Drug-induced Aseptic Meningitis: Pharmacovigilance Analysis of Japanese Adverse Event Reporting Database

Prescription Monitoring Program Review Among Patients with Cancer Receiving Opioids at a Safety-Net Palliative Medicine Clinic

Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System

Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024

Automated dispensing cabinets and nurse-related medication errors in inpatient settings: A systematic review

MHRA Warns of Rare Severe Pancreatitis With GLP-1 Drugs